Norwegian Cruise Line Holdings Ltd. · NCLH · FY2025 Q2 · Calendar Q3 2025

NCLH Reaffirms Targets as Yield Growth and Island Investment Advance

The supplied analysis supports a constructive but conditional view of NCLH’s operating trajectory: resilient demand, yield growth, new capacity, island investment, and cost actions support the earnings-growth case, while European softness, foreign exchange, execution risk, and discretionary-spending uncertainty remain material tests.

Reported Before market openNYSEConsumer Cyclical $6.57B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.51 Consensus $0.52
EPS surprise -1.9% Reported versus consensus
Reported revenue $2.52B Consensus $3.02B
Revenue surprise -16.5% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +9.2% Event window
SPY move -0.4% Same window
Abnormal move +9.6% Stock minus SPY
Volume 2.9× Versus trailing sessions
Subsequent drift -0.7% Up to 20 sessions
NCLHSPY benchmark

Ask FN2 about NCLH FY2025 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the supplied Q2 review points to another quarter above guidance, continued progress on cost savings and leverage, and further detail on Great Stirrup Cay, luxury-ship capacity, and the revenue-management rollout.

Guidance delta

Full-year targets were reaffirmed; management continued to emphasize sub-inflationary unit-cost growth, margin expansion, and leverage reduction objectives.

Key takeaways

  • Q2 revenue, adjusted EBITDA, and net yield exceeded guidance, according to the supplied transcript analysis.
  • Great Stirrup Cay upgrades and new ships are central to the onboard-spend and capacity strategy.
  • Management highlighted improving leverage, cost savings, and a new revenue-management system while noting Europe, foreign exchange, and discretionary-spending risks.

Management priorities

  • Expand capacity and onboard spend through new ships and Great Stirrup Cay enhancements.
  • Deliver more than $300 million of targeted cost savings and keep unit-cost growth below inflation.
  • Roll out the revenue-management system and pursue margin and leverage improvement through 2026.

Follow NCLH with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
NCLH EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $0.12 Q1 '24 actual $0.16, beat Q2 '24 estimate $0.35 Q2 '24 actual $0.40, beat Q3 '24 estimate $0.94 Q3 '24 actual $0.99, beat Q2 '25 estimate $0.52 Q2 '25 actual $0.51, match Q3 '25 estimate $1.16 Q3 '25 actual $1.20, beat Q4 '25 estimate $0.26 Q4 '25 actual $0.28, beat Q1 '26 estimate $0.15 Q1 '26 actual $0.23, beat Q2 '26 estimate $0.41 Q2 '26 actual $0.48, beat Q3 '26 estimate $0.90 Q4 '26 estimate $0.13 Q1 '27 estimate $-0.01
Show 1 more >

Analyst Consensus ?

ConsensusHold37 ratings
Bullish1951.4%
Neutral1745.9%
Bearish12.7%

Analyst 52W Price Targets

$14.31Previous close
$13Low
$23.61Average
$45High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 29, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Truist Securities Hold HoldMaintainSep 24, 2026
JP Morgan Neutral NeutralMaintainSep 24, 2026
Wells Fargo Overweight OverweightMaintainSep 4, 2026
UBS Neutral NeutralMaintainAug 18, 2026
Mizuho Neutral OutperformDowngradeAug 18, 2026
Stifel Buy BuyMaintainJul 31, 2026
Citigroup Buy BuyMaintainJul 31, 2026
Barclays Equal Weight Equal WeightMaintainJul 31, 2026
Jefferies Hold HoldMaintainJul 17, 2026
Goldman Sachs Neutral NeutralMaintainJul 14, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJul 9, 2026
TD Cowen Buy BuyMaintainJun 23, 2026
Susquehanna Neutral NeutralMaintainMay 5, 2026
Tigress Financial Strong Buy Strong BuyMaintainApr 17, 2026
B of A Securities Neutral NeutralMaintainMar 3, 2026
Macquarie Outperform OutperformMaintainMay 9, 2025
Loop Capital Buy BuyMaintainMay 1, 2025
Argus Research Buy HoldUpgradeNov 4, 2024
Deutsche Bank Hold HoldMaintainNov 1, 2024
Redburn Partners Buy NeutralUpgradeSep 14, 2023
Credit Suisse Neutral NeutralMaintainMay 2, 2023
Wolfe Research Outperform Peer PerformUpgradeJun 16, 2021
Berenberg Hold BuyDowngradeFeb 12, 2021
SunTrust Robinson Humphrey Hold BuyDowngradeJul 14, 2020
Redburn Neutral BuyDowngradeJun 22, 2020
Nomura Buy BuyMaintainApr 8, 2020
CFRA Sell Strong SellMaintainMar 2, 2020
Wedbush Outperform OutperformMaintainFeb 21, 2020
Stifel Nicolaus Buy BuyMaintainFeb 21, 2020
Buckingham Research Buy BuyMaintainNov 8, 2019
Buckingham Buy BuyMaintainNov 8, 2019
Bank of America Buy BuyMaintainAug 9, 2019
Bernstein Outperform Market PerformUpgradeJan 8, 2019
Argus Buy BuyMaintainOct 25, 2017
Sterne Agee CRT Buy BuyMaintainJun 7, 2016
DNB Markets Hold BuyDowngradeDec 18, 2014
Longbow Research Neutral BuyDowngradeJun 4, 2014
Show less

Named analyst price targets

Upside is calculated against the persisted previous close $14.31. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialPatrick Scholes$16$14.17 +11.8%Sep 24, 2026
Canaccord GenuityJoseph Vafi$45$18.18 +214.5%Aug 18, 2026
UBSAnalyst unavailable$20$18.18 +39.8%Aug 18, 2026
Mizuho SecuritiesBen Chaiken$17$18.18 +18.8%Aug 18, 2026
SusquehannaAnalyst unavailable$17$19.82 +18.8%Aug 4, 2026
Deutsche BankAnalyst unavailable$17$18.47 +18.8%Jul 31, 2026
Mizuho SecuritiesAnalyst unavailable$22$18.72 +53.7%Jul 31, 2026
BarclaysAnalyst unavailable$18$18.72 +25.8%Jul 31, 2026
JefferiesAnalyst unavailable$18$19.61 +25.8%Jul 17, 2026
Goldman SachsLizzie Dove$16$19.63 +11.8%Jul 14, 2026
Morgan StanleyAnalyst unavailable$22$19.14 +53.7%Jul 9, 2026
BMO CapitalTristan Thomas-Martin$21$18.83 +46.8%Jul 7, 2026
Wells FargoAnalyst unavailable$25$21.11 +74.7%Jul 1, 2026
BernsteinRichard Clarke$18$18.13 +25.8%Jun 3, 2026
Loop Capital MarketsAnalyst unavailable$22$18.34 +53.7%Jun 1, 2026
UBSRobin Farley$17$14.94 +18.8%May 19, 2026
Deutsche BankAnalyst unavailable$18$17.34 +25.8%May 5, 2026
SusquehannaAnalyst unavailable$15$17.2 +4.8%May 5, 2026
Morgan StanleyAnalyst unavailable$20$17.2 +39.8%May 5, 2026
Goldman SachsAnalyst unavailable$14$17.2 -2.2%May 5, 2026
BarclaysAnalyst unavailable$19$17.2 +32.8%May 5, 2026
Wells FargoAnalyst unavailable$26$21.09 +81.7%Apr 15, 2026
BarclaysAnalyst unavailable$21$19.76 +46.8%Apr 10, 2026
Morgan StanleyStephen Grambling$23$19.96 +60.7%Apr 9, 2026
Mizuho SecuritiesAnalyst unavailable$27$20.16 +88.7%Apr 8, 2026
Wolfe ResearchGreg Badishkanian$25$22.18 +74.7%Mar 3, 2026
Stifel NicolausSteven Wieczynski$30$22.18 +109.6%Mar 3, 2026
Morgan StanleyStephen Grambling$25$22.18 +74.7%Mar 3, 2026
NeedhamAnalyst unavailable$27$22.18 +88.7%Mar 3, 2026
Goldman SachsLizzie Dove$20$22.18 +39.8%Mar 3, 2026
Mizuho SecuritiesBen Chaiken$28$22.18 +95.7%Mar 2, 2026
Stifel NicolausSteven Wieczynski$31$23.56 +116.6%Feb 11, 2026
Wells FargoAnalyst unavailable$33$24.34 +130.6%Jan 13, 2026
BarclaysAnalyst unavailable$23$21.54 +60.7%Dec 17, 2025
JefferiesAnalyst unavailable$20$20.86 +39.8%Dec 15, 2025
Mizuho SecuritiesAnalyst unavailable$32$20.56 +123.6%Dec 12, 2025
Goldman SachsAnalyst unavailable$21$19.11 +46.8%Dec 9, 2025
Truist FinancialAnalyst unavailable$26$18.57 +81.7%Dec 2, 2025
SusquehannaChristopher Stathoulopoulos$21$18.82 +46.8%Nov 12, 2025
Goldman SachsAnalyst unavailable$27$18.4 +88.7%Nov 5, 2025
BarclaysBrandt Montour$28$18.79 +95.7%Nov 5, 2025
Truist FinancialPatrick Scholes$31$25.41 +116.6%Sep 19, 2025
Tigress FinancialIvan Feinseth$38$24.74 +165.5%Aug 27, 2025
UBSAnalyst unavailable$27$24.45 +88.7%Aug 26, 2025
Goldman SachsLizzie Dove$34$26.42 +137.6%Jan 23, 2025
Truist FinancialPatrick Scholes$35$28.4 +144.6%Dec 2, 2024
Tigress FinancialIvan Feinseth$36$27.82 +151.6%Nov 11, 2024
MacquariePaul Golding$30$24.88 +109.6%Nov 1, 2024
Morgan StanleyStephen Grambling$19$23.96 +32.8%Oct 30, 2024
BarclaysBrandt Montour$26$23.71 +81.7%Oct 22, 2024
CitigroupJames Hardiman$30$23.07 +109.6%Oct 9, 2024
Stifel NicolausSteven Wieczynski$29$20.39 +102.7%Oct 4, 2024
Mizuho SecuritiesBen Chaiken$26$17.94 +81.7%Sep 11, 2024
Truist FinancialPatrick Scholes$21$16.56 +46.8%May 29, 2024
Mizuho SecuritiesBen Chaiken$24$16 +67.7%May 28, 2024
Deutsche BankChris Woronka$20$16.94 +39.8%May 21, 2024
BarclaysBrandt Montour$20$16.94 +39.8%May 21, 2024
UBSRobin Farley$19$16.94 +32.8%May 21, 2024
Wells FargoDaniel Politzer$20$16.94 +39.8%May 21, 2024
Stifel NicolausSteven Wieczynski$26$16.94 +81.7%May 21, 2024
Wells FargoDaniel Politzer$19$16.08 +32.8%May 2, 2024
Stifel NicolausSteven Wieczynski$25$19.17 +74.7%Apr 9, 2024
Mizuho SecuritiesBen Chaiken$21$20.54 +46.8%Mar 25, 2024
Goldman SachsLizzie Dove$19$19.87 +32.8%Mar 13, 2024
Redburn PartnersAlex Brignall$25$15.18 +74.7%Sep 25, 2023
Morgan StanleyAnalyst unavailable$11.5$13.75 -19.6%Jan 10, 2023
UBSAnalyst unavailable$13$13.8 -9.2%Jan 9, 2023
UBSAnalyst unavailable$19$15.46 +32.8%Dec 13, 2022
J.P. MorganAnalyst unavailable$30$15.64 +109.6%Dec 6, 2022
Truist FinancialAnalyst unavailable$21$16.12 +46.8%Nov 22, 2022
Credit SuisseAnalyst unavailable$14$17.59 -2.2%Nov 17, 2022
UBSAnalyst unavailable$24$17.87 +67.7%Nov 14, 2022
Tigress FinancialIvan Feinseth$32$14.62 +123.6%Oct 21, 2022
Morgan StanleyThomas Allen$13$14.16 -9.2%Aug 12, 2022
Morgan StanleyThomas Allen$14$11.43 -2.2%Jun 20, 2022
SusquehannaChristopher Stathoulopoulos$20$11.43 +39.8%Jun 18, 2022
Morgan StanleyThomas Allen$18$16.14 +25.8%May 13, 2022
CitigroupAnalyst unavailable$24$22.22 +67.7%Apr 19, 2022
Truist FinancialPatrick Scholes$20$19.86 +39.8%Mar 25, 2022
MacquariePaul Golding$23$17.39 +60.7%Mar 4, 2022
CitigroupJames Ainley$25$22.63 +74.7%Feb 10, 2022
J.P. MorganBrandt Montour$37$24.66 +158.6%Aug 9, 2021
UBSRobin M. Farley$29$27.66 +102.7%May 11, 2021
Goldman SachsStephen Grambling$37$26.75 +158.6%Apr 20, 2021
Show less

Track every rating change on NCLH the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Norwegian Cruise Line Holdings Ltd. (NCLH), along with its subsidiary companies, operates as a major global cruise enterprise. Its operations span North America, Europe, the Asia-Pacific region, and other international markets. The company manages a portfolio of three distinct cruise brands: Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. NCLH offers an extensive range of voyages, from brief three-day excursions to lengthy 180-day expeditions.…

Historical context

All NCLH earnings

Consumer Cyclical peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the NCLH recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
  3. Polygon adjusted daily market bars · 2026-09-29T07:31:02.760447+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T07:31:02.757721+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.